ABSTRACT A new dominant mutation in the laboratory mouse, hypophosphatemia (gene symbol Hyp), has been identified. The Hyp gene is located on the X-chromosome and maps at the distal end. Mutant mice are characterized by hypophosphatemia, bone changes resembling rickets, diminished bone ash, dwarfism, and high fractional excretion of phosphate anion (low net tubular reabsorption We report the discovery of an X-linked dominant mutation named hypophosphatemia (gene symbol Hyp) in the laboratory mouse. Our findings indicate that the disease seen in the hypophosphatemic mouse is similar to XLH. Because both diseases are inherited as X-linked dominants, it is highly probable that the human and mouse diseases are caused by mutations affecting the homologous gene. Accordingly, the mouse should be a valuable model for elucidation of the basic defect in human XLH.
etal abnormalities. The hypo hosphatemic male mouse resembles human males with X inked hypophosphatemia and the Hyp gene is presumably homologous with the X-linked human gene. The mouse model should facilitate study of the defect in transport of plasma inorganic phosphate anion. Familial vitamin D-resistant rickets or X-linked hypophosphatemia (XLH) is characterized by X-linked dominant inheritance. Affected individuals have essentially normal serum calcium levels, hypophosphatemia, impaired net renal tubular reabsorption of phosphate anion, shortened stature, and vitamin D nonresponsive rickets or osteomalacia (1, 2) . Although several hypotheses have been put forth, precise etiology of the disease remains unknown.
We report the discovery of an X-linked dominant mutation named hypophosphatemia (gene symbol Hyp) in the laboratory mouse. Our findings indicate that the disease seen in the hypophosphatemic mouse is similar to XLH. Because both diseases are inherited as X-linked dominants, it is highly probable that the human and mouse diseases are caused by mutations affecting the homologous gene. Accordingly, the mouse should be a valuable model for elucidation of the basic defect in human XLH.
MATERIALS AND METHODS
Origin and Genetics. In 1966, six male mice with shortened trunk and hind limbs were noted in a linkage experiment at the Jackson Laboratory. By appropriate crosses, the new mutation was shown to be dominant and X-linked. Because the affected mice had a low serum phosphorus concentration, the mutation was named hypophosphatemia, gene symbol Hyp. Soon after its discovery, the mutant Hyp allele was transferred to the C57BL/6J inbred strain by repeated matings of Hyp/+ females to C57BL/6J +/Y males. All growth and physiological studies were conducted on mice of the C57BL/6J-Hyp strain.
Diet. Unless otherwise noted, all mice were fed the mouse diet Old Guilford 96W containing 22.5% protein, 7.5% fat, 0.6% vitamin supplement, 0.22% calcium, and 0.74% phosphorus (wt/wt). The drinking water was acidified. Food and water were available ad libitum.
Linkage. In order to determine the position of Hyp on the X chromosome, the following experiment was conducted. Females that were + + Hyp/+ + + were mated to a Ta Bn +/Y male (Ta = tabby; Bn = bent-tail). The (9) .
Solutes other than Pi (e.g., amino acids or glucose) were not (9, 13, 14) . However is it undecided whether the primary defect involves (a) a luminal membrane-located anion carrier, (b) a disorder in cell responsiveness to agents that regulate Pi transport, (c) a postulated but as yet unidentified humoral modulator of phosphate transport, or (d) a disruption in vitamin D metabolism or function.
The presence of a mutant homologous nonhuman model of XLH should permit studies to be undertaken that cannot be performed in man. These would include the measurement in vitro of transepithelial Pi transport by intestine, where only uptake studies by mucosal biopsies have been done in man (15, 16) , parabiosis (cross circulation) experiments to determine whether an abnormal circulating factor is present or a normal factor is missing, study of the homozygous female (Hyp/Hyp) to examine mutant gene dosage effects independent of possible sex-dependent modulation of the gene's expression, micropuncture studies to determine Pi handling at various sites in the tubule of Hyp/Y mice, and experiments to determine whether a defect in vitamin D metabolism exists in Hyp/Y and Hyp/+ mice.
The hypophosphatemia mutant mouse serving as a genetic probe should yield a clearer picture than exists at present about the events controlling Pi anion transport in the epithelia of metazoa.
